Azher Hussain

Assessment of the Effect of Pyrimethamine, a Potent Inhibitor of Multidrug and Toxin Extrusion Protein 1/2K, on the Pharmacokinetics of Gefapixant (MK‐7264), a P2X3 Receptor Antagonist

B. Ma, R. Evers, G. Garrett, 2021, Clinical pharmacology in drug development.

Assessment of floristic diversity in the desert ecosystem of central Karakoram National Park (Karakoram Range) Gilgit-Baltistan, Pakistan

A. Hussain, Haibat Ali, Sajid Ali, 2021 .

PK of immunoconjugate anticancer agent CMD-193 in rats: ligand-binding assay approach to determine in vivo immunoconjugate stability.

E. Fluhler, B. Gorovits, M. Leal, 2014, Bioanalysis.

Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis

M. Iwamoto, M. Martinho, P. Shaw, 2018, British journal of clinical pharmacology.

The effect of the neonatal Fc receptor on human IgG biodistribution in mice

Scott E. Fauty, T. Prueksaritanont, Weirong Wang, 2014, mAbs.

Controversy in the allometric application of fixed- versus varying-exponent models: a statistical and mathematical perspective.

Huadong Tang, E. Fluhler, M. Mayersohn, 2011, Journal of pharmaceutical sciences.

Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species

Mauricio Leal, Eric Fluhler, Michael Mayersohn, 2007, Drug Metabolism and Disposition.

Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors.

S. Peters, J. Soria, A. Stathis, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical application of volumetric absorptive microsampling to the gefapixant development program.

K. Bateman, E. Woolf, F. Vazvaei, 2020, Bioanalysis.

Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis

T. Kerbusch, Suresh Vatakuti, P. Kulkarni, 2019, Clinical Pharmacokinetics.

A Mathematical Simulation to Explain the Coordinated Functions of Efflux and Metabolism Limiting the Transport of Anti-HIV Agents Across Caco-2 Cells

A. Mitra, J. Patel, Azher Hussain, 2004, American journal of therapeutics.